Frontiers in pharmacology · 2026
Total alkaloids of Leonurus alleviate allergic asthma and inflammation responses by inhibiting hypoxia-induced factor-1⍺-mediated mast cell activation.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zheng Yannan, Lv Mingyue, Xi Zhichao, Sun Jijia, Liu Mengfan, Thi Nguyen Trinh Thach, Zhang Hongmei, Li Songlin, Zheng Min, Wan Shijie, Li Hua, Yuan Man, Xu Hongxi
Аннотация
BACKGROUND: Leonurus japonicus Houtt. has been traditionally used as a gynecological remedy and is now recognized for its anti-inflammatory and immunomodulatory properties. But its potential therapeutic role in allergic asthma is unclear. This study aimed to investigate the anti-asthmatic effects of the total alkaloids of Leonurus (TAL) and their regulation of mast cell activation through the hypoxia-inducible factor-1α (HIF-1α) pathway.
MATERIALS AND METHODS: An ovalbumin (OVA)-induced asthma mouse model was used to detect TAL's effects on airway hyperresponsiveness, lung inflammation, and Th2 cytokines. For in vitro studies, RBL-2H3 cells were employed as a mast cell model. Transcriptomics and cross-species analysis integrated rat signatures with human asthma datasets using KEGG enrichment to identify conserved HIF-1α-related pathways. HIF-1α expression and localization were analyzed by Western blotting and immunofluorescence. Mast cell degranulation was evaluated via β-hexosaminidase (β-hex) assay and Th2 cytokines detection. Constructed a HIF-1α stable overexpression cell or applied pharmacological inhibition (YC-1) to verify the key role of HIF-1⍺ on TAL's efficacy.
RESULTS: TAL significantly alleviated allergic symptoms, reduced airway hyperresponsiveness, and decreased lung mast cell infiltration. Transcriptomic analysis revealed that hypoxia-related pathways, particularly HIF-1α, were downregulated following TAL intervention. TAL suppressed HIF-1α protein expression, reduced mast cell degranulation, and Th2 cytokines both in vivo and in vitro. Mechanistically, hypoxia induced HIF-1α upregulation, mast cell activation, and cytokine release, whereas TAL inhibited these responses. This effect was weakened by HIF-1α overexpression but potentiated by YC-1.
CONCLUSION: TAL alleviates allergic asthma by suppressing HIF-1α-mediated mast cell activation and associated inflammation responses, supporting its potential application in inflammatory airway diseases.
MATERIALS AND METHODS: An ovalbumin (OVA)-induced asthma mouse model was used to detect TAL's effects on airway hyperresponsiveness, lung inflammation, and Th2 cytokines. For in vitro studies, RBL-2H3 cells were employed as a mast cell model. Transcriptomics and cross-species analysis integrated rat signatures with human asthma datasets using KEGG enrichment to identify conserved HIF-1α-related pathways. HIF-1α expression and localization were analyzed by Western blotting and immunofluorescence. Mast cell degranulation was evaluated via β-hexosaminidase (β-hex) assay and Th2 cytokines detection. Constructed a HIF-1α stable overexpression cell or applied pharmacological inhibition (YC-1) to verify the key role of HIF-1⍺ on TAL's efficacy.
RESULTS: TAL significantly alleviated allergic symptoms, reduced airway hyperresponsiveness, and decreased lung mast cell infiltration. Transcriptomic analysis revealed that hypoxia-related pathways, particularly HIF-1α, were downregulated following TAL intervention. TAL suppressed HIF-1α protein expression, reduced mast cell degranulation, and Th2 cytokines both in vivo and in vitro. Mechanistically, hypoxia induced HIF-1α upregulation, mast cell activation, and cytokine release, whereas TAL inhibited these responses. This effect was weakened by HIF-1α overexpression but potentiated by YC-1.
CONCLUSION: TAL alleviates allergic asthma by suppressing HIF-1α-mediated mast cell activation and associated inflammation responses, supporting its potential application in inflammatory airway diseases.